Vital Bio key facts
- Developer of advanced diagnostic technologies designed to bridge the gap between diagnosis and treatment.
- It has raised $62.1M; the latest was Later Stage VC in Sep 2024.
- Notable investors include FJ Labs, 8VC, Abstract Ventures, University of Toronto Entrepreneurship, FundersClub — 25 tracked in total.
- Status: Privately Held (backing).
Who backs Vital Bio
25+- ·The complete investor list: 25 names
- ·Watch Vital Bio: the Monday email on marks, rounds and moves
Vital Bio funding rounds
No funding rounds for Vital Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Vital Bio investors
25 investors are on record for Vital Bio, including FJ Labs, 8VC, Abstract Ventures and University of Toronto Entrepreneurship. By type, the record holds 6 venture capital firms and 1 family office.
About Vital Bio
Developer of advanced diagnostic technologies designed to bridge the gap between diagnosis and treatment. The company's technology offers an ecosystem of devices, software, and services that aim to make healthcare radically more personalized, proactive, and accessible, enabling clinicians to reduce inequality of well-being, redistribute control to patients, and empower healthcare providers to create better outcomes.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2016
- Employees
- 193
- Website
- vitalbio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Vital Bio doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.